nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.132	0.197	CbGbCtD
Alosetron—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0955	0.142	CbGbCtD
Alosetron—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.08	0.119	CbGbCtD
Alosetron—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0764	0.114	CbGbCtD
Alosetron—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0646	0.0963	CbGbCtD
Alosetron—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.05	0.0746	CbGbCtD
Alosetron—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0465	0.0693	CbGbCtD
Alosetron—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0374	0.0557	CbGbCtD
Alosetron—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0343	0.0511	CbGbCtD
Alosetron—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0214	0.0318	CbGbCtD
Alosetron—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0196	0.0292	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0134	0.0199	CbGbCtD
Alosetron—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.00633	0.341	CbGeAlD
Alosetron—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00482	0.26	CbGeAlD
Alosetron—HTR3A—nerve—peripheral nervous system neoplasm	0.00247	0.133	CbGeAlD
Alosetron—HTR3A—ganglion—peripheral nervous system neoplasm	0.00244	0.131	CbGeAlD
Alosetron—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.0012	0.0646	CbGeAlD
Alosetron—HTR3A—brainstem—peripheral nervous system neoplasm	0.00106	0.0571	CbGeAlD
Alosetron—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000488	0.00157	CcSEcCtD
Alosetron—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.000488	0.00157	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000485	0.00156	CcSEcCtD
Alosetron—Bone pain—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.00156	CcSEcCtD
Alosetron—Cystitis—Epirubicin—peripheral nervous system neoplasm	0.000484	0.00156	CcSEcCtD
Alosetron—Colitis—Epirubicin—peripheral nervous system neoplasm	0.000482	0.00155	CcSEcCtD
Alosetron—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00047	0.00151	CcSEcCtD
Alosetron—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000469	0.00151	CcSEcCtD
Alosetron—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000465	0.0015	CcSEcCtD
Alosetron—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000465	0.0015	CcSEcCtD
Alosetron—Pain—Topotecan—peripheral nervous system neoplasm	0.000465	0.0015	CcSEcCtD
Alosetron—Constipation—Topotecan—peripheral nervous system neoplasm	0.000465	0.0015	CcSEcCtD
Alosetron—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000465	0.0015	CcSEcCtD
Alosetron—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000462	0.00149	CcSEcCtD
Alosetron—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000462	0.00149	CcSEcCtD
Alosetron—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000462	0.00149	CcSEcCtD
Alosetron—Pain—Tretinoin—peripheral nervous system neoplasm	0.000462	0.00149	CcSEcCtD
Alosetron—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00046	0.00148	CcSEcCtD
Alosetron—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000459	0.00148	CcSEcCtD
Alosetron—Abnormal dreams—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.00148	CcSEcCtD
Alosetron—Pain—Melphalan—peripheral nervous system neoplasm	0.000456	0.00147	CcSEcCtD
Alosetron—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000455	0.00146	CcSEcCtD
Alosetron—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.000454	0.00146	CcSEcCtD
Alosetron—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00146	CcSEcCtD
Alosetron—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000452	0.00146	CcSEcCtD
Alosetron—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000448	0.00144	CcSEcCtD
Alosetron—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.00144	CcSEcCtD
Alosetron—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000447	0.00144	CcSEcCtD
Alosetron—Colitis—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.00144	CcSEcCtD
Alosetron—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000445	0.00143	CcSEcCtD
Alosetron—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000445	0.00143	CcSEcCtD
Alosetron—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000438	0.00141	CcSEcCtD
Alosetron—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000438	0.00141	CcSEcCtD
Alosetron—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.00141	CcSEcCtD
Alosetron—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000434	0.0014	CcSEcCtD
Alosetron—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.00139	CcSEcCtD
Alosetron—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000432	0.00139	CcSEcCtD
Alosetron—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000429	0.00138	CcSEcCtD
Alosetron—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000429	0.00138	CcSEcCtD
Alosetron—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000427	0.00137	CcSEcCtD
Alosetron—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00137	CcSEcCtD
Alosetron—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000423	0.00136	CcSEcCtD
Alosetron—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.00136	CcSEcCtD
Alosetron—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000421	0.00136	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00135	CcSEcCtD
Alosetron—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00134	CcSEcCtD
Alosetron—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000417	0.00134	CcSEcCtD
Alosetron—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.00133	CcSEcCtD
Alosetron—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000411	0.00132	CcSEcCtD
Alosetron—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000411	0.00132	CcSEcCtD
Alosetron—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.00131	CcSEcCtD
Alosetron—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000405	0.00131	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000402	0.00129	CcSEcCtD
Alosetron—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000401	0.00129	CcSEcCtD
Alosetron—Tremor—Cisplatin—peripheral nervous system neoplasm	0.0004	0.00129	CcSEcCtD
Alosetron—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000398	0.00128	CcSEcCtD
Alosetron—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000398	0.00128	CcSEcCtD
Alosetron—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.00128	CcSEcCtD
Alosetron—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000397	0.00128	CcSEcCtD
Alosetron—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000396	0.00128	CcSEcCtD
Alosetron—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.00127	CcSEcCtD
Alosetron—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000393	0.00126	CcSEcCtD
Alosetron—Infection—Vincristine—peripheral nervous system neoplasm	0.000392	0.00126	CcSEcCtD
Alosetron—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00039	0.00126	CcSEcCtD
Alosetron—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000387	0.00125	CcSEcCtD
Alosetron—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000387	0.00125	CcSEcCtD
Alosetron—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000385	0.00124	CcSEcCtD
Alosetron—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000382	0.00123	CcSEcCtD
Alosetron—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000381	0.00123	CcSEcCtD
Alosetron—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00038	0.00123	CcSEcCtD
Alosetron—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000377	0.00122	CcSEcCtD
Alosetron—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000376	0.00121	CcSEcCtD
Alosetron—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.00121	CcSEcCtD
Alosetron—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000373	0.0012	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000373	0.0012	CcSEcCtD
Alosetron—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000364	0.00117	CcSEcCtD
Alosetron—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.00117	CcSEcCtD
Alosetron—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000363	0.00117	CcSEcCtD
Alosetron—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000362	0.00117	CcSEcCtD
Alosetron—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000359	0.00116	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000359	0.00116	CcSEcCtD
Alosetron—Malaise—Etoposide—peripheral nervous system neoplasm	0.000353	0.00114	CcSEcCtD
Alosetron—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.00114	CcSEcCtD
Alosetron—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.00113	CcSEcCtD
Alosetron—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.00113	CcSEcCtD
Alosetron—Infection—Cisplatin—peripheral nervous system neoplasm	0.000346	0.00112	CcSEcCtD
Alosetron—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000346	0.00111	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.00111	CcSEcCtD
Alosetron—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000343	0.00111	CcSEcCtD
Alosetron—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000343	0.00111	CcSEcCtD
Alosetron—Rash—Topotecan—peripheral nervous system neoplasm	0.000343	0.00111	CcSEcCtD
Alosetron—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000343	0.0011	CcSEcCtD
Alosetron—Cough—Etoposide—peripheral nervous system neoplasm	0.000341	0.0011	CcSEcCtD
Alosetron—Headache—Topotecan—peripheral nervous system neoplasm	0.000341	0.0011	CcSEcCtD
Alosetron—Rash—Tretinoin—peripheral nervous system neoplasm	0.00034	0.0011	CcSEcCtD
Alosetron—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00034	0.0011	CcSEcCtD
Alosetron—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00034	0.0011	CcSEcCtD
Alosetron—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00034	0.0011	CcSEcCtD
Alosetron—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00034	0.00109	CcSEcCtD
Alosetron—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000339	0.00109	CcSEcCtD
Alosetron—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000339	0.00109	CcSEcCtD
Alosetron—Headache—Tretinoin—peripheral nervous system neoplasm	0.000338	0.00109	CcSEcCtD
Alosetron—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.00109	CcSEcCtD
Alosetron—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000338	0.00109	CcSEcCtD
Alosetron—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.00109	CcSEcCtD
Alosetron—Constipation—Vincristine—peripheral nervous system neoplasm	0.000337	0.00109	CcSEcCtD
Alosetron—Pain—Vincristine—peripheral nervous system neoplasm	0.000337	0.00109	CcSEcCtD
Alosetron—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000337	0.00109	CcSEcCtD
Alosetron—Rash—Melphalan—peripheral nervous system neoplasm	0.000336	0.00108	CcSEcCtD
Alosetron—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000336	0.00108	CcSEcCtD
Alosetron—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00107	CcSEcCtD
Alosetron—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000329	0.00106	CcSEcCtD
Alosetron—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00105	CcSEcCtD
Alosetron—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000325	0.00105	CcSEcCtD
Alosetron—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.00105	CcSEcCtD
Alosetron—Nausea—Topotecan—peripheral nervous system neoplasm	0.000323	0.00104	CcSEcCtD
Alosetron—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00104	CcSEcCtD
Alosetron—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000322	0.00104	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000321	0.00103	CcSEcCtD
Alosetron—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.00103	CcSEcCtD
Alosetron—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000321	0.00103	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000318	0.00102	CcSEcCtD
Alosetron—Infection—Etoposide—peripheral nervous system neoplasm	0.000317	0.00102	CcSEcCtD
Alosetron—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00102	CcSEcCtD
Alosetron—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.00102	CcSEcCtD
Alosetron—Nausea—Melphalan—peripheral nervous system neoplasm	0.000316	0.00102	CcSEcCtD
Alosetron—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00031	0.000999	CcSEcCtD
Alosetron—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000309	0.000994	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000991	CcSEcCtD
Alosetron—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.000971	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000971	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000961	CcSEcCtD
Alosetron—Pain—Cisplatin—peripheral nervous system neoplasm	0.000298	0.00096	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000957	CcSEcCtD
Alosetron—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000945	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000944	CcSEcCtD
Alosetron—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000942	CcSEcCtD
Alosetron—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000937	CcSEcCtD
Alosetron—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00029	0.000935	CcSEcCtD
Alosetron—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000925	CcSEcCtD
Alosetron—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000915	CcSEcCtD
Alosetron—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000283	0.000911	CcSEcCtD
Alosetron—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000281	0.000904	CcSEcCtD
Alosetron—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000278	0.000896	CcSEcCtD
Alosetron—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000275	0.000887	CcSEcCtD
Alosetron—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000881	CcSEcCtD
Alosetron—Pain—Etoposide—peripheral nervous system neoplasm	0.000273	0.00088	CcSEcCtD
Alosetron—Constipation—Etoposide—peripheral nervous system neoplasm	0.000273	0.00088	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000879	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000872	CcSEcCtD
Alosetron—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000867	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000867	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000848	CcSEcCtD
Alosetron—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000263	0.000848	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000846	CcSEcCtD
Alosetron—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000262	0.000844	CcSEcCtD
Alosetron—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00026	0.000838	CcSEcCtD
Alosetron—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.000831	CcSEcCtD
Alosetron—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00083	CcSEcCtD
Alosetron—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000257	0.000827	CcSEcCtD
Alosetron—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.000825	CcSEcCtD
Alosetron—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000254	0.000817	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000816	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000815	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000813	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000812	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000812	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000807	CcSEcCtD
Alosetron—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000251	0.000807	CcSEcCtD
Alosetron—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000806	CcSEcCtD
Alosetron—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000802	CcSEcCtD
Alosetron—Rash—Vincristine—peripheral nervous system neoplasm	0.000249	0.000801	CcSEcCtD
Alosetron—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000248	0.0008	CcSEcCtD
Alosetron—Headache—Vincristine—peripheral nervous system neoplasm	0.000247	0.000795	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000785	CcSEcCtD
Alosetron—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.000783	CcSEcCtD
Alosetron—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000243	0.0131	CbGeAlD
Alosetron—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000235	0.000758	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000755	CcSEcCtD
Alosetron—Nausea—Vincristine—peripheral nervous system neoplasm	0.000234	0.000754	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000751	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000751	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000747	CcSEcCtD
Alosetron—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000229	0.000738	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000725	CcSEcCtD
Alosetron—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000717	CcSEcCtD
Alosetron—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000714	CcSEcCtD
Alosetron—Rash—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000708	CcSEcCtD
Alosetron—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000707	CcSEcCtD
Alosetron—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000696	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000679	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000671	CcSEcCtD
Alosetron—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000207	0.000667	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000664	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000655	CcSEcCtD
Alosetron—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000203	0.000654	CcSEcCtD
Alosetron—Rash—Etoposide—peripheral nervous system neoplasm	0.000201	0.000649	CcSEcCtD
Alosetron—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000201	0.000648	CcSEcCtD
Alosetron—Headache—Etoposide—peripheral nervous system neoplasm	0.0002	0.000644	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000644	CcSEcCtD
Alosetron—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000637	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000628	CcSEcCtD
Alosetron—Cough—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000616	CcSEcCtD
Alosetron—Nausea—Etoposide—peripheral nervous system neoplasm	0.00019	0.000611	CcSEcCtD
Alosetron—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00061	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000606	CcSEcCtD
Alosetron—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000601	CcSEcCtD
Alosetron—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000599	CcSEcCtD
Alosetron—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000594	CcSEcCtD
Alosetron—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000589	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000588	CcSEcCtD
Alosetron—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000581	CcSEcCtD
Alosetron—Infection—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000573	CcSEcCtD
Alosetron—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00057	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000564	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00056	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000557	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000557	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000555	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00055	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000544	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000538	CcSEcCtD
Alosetron—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00053	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000525	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000518	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000516	CcSEcCtD
Alosetron—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000497	CcSEcCtD
Alosetron—Pain—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000493	CcSEcCtD
Alosetron—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000493	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000486	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000475	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00046	CcSEcCtD
Alosetron—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000458	CcSEcCtD
Alosetron—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000456	CcSEcCtD
Alosetron—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000456	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00044	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000425	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000424	CcSEcCtD
Alosetron—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000414	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000393	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000383	CcSEcCtD
Alosetron—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000367	CcSEcCtD
Alosetron—Rash—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000364	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000363	CcSEcCtD
Alosetron—Headache—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000361	CcSEcCtD
Alosetron—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000342	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000339	CcSEcCtD
Alosetron—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000336	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000336	CcSEcCtD
Alosetron—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000334	CcSEcCtD
Alosetron—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000317	CcSEcCtD
